Faricimab CAS#: 1607793-29-2; 凯望编码 (ChemWhat Code): 1417436
Identification
| 英文名 | Faricimab |
| IUPAC Name | |
| CAS编号 | 1607793-29-2 |
| 分子式 | |
| 分子量 | |
| InChI | |
| InChI Key | |
| Canonical SMILES |
Physical Data
No data available
Spectra
No data available
Route of Synthesis (ROS)
No data available
Safety and Hazards
No data available
Other Data
No data available
| Use Pattern |
| Faricimab CAS#: 1607793-29-2 is a bispecific antibody that is promising for the treatment of wet age-related macular degeneration (AMD) and diabetic macular edema (DME). It simultaneously targets and blocks two key pathogenic pathways – angiopoietin-2 (Ang). -2) and vascular endothelial growth factor-A (VEGF-A), two pathways that drive many retinal diseases that lead to vision loss by destabilizing blood vessels. mRNAs. |
试剂采购 | |
| 没有试剂厂商? | 向凯望发送快速询价 |
| 想要被列为试剂厂商? (付费服务) | 点击这里联系凯望 |
认证生产商 | |
| Watson Bio Ltd | https://www.watson-bio.com/ |
| 想要被列为认证生产商 (需要通过认证)? | 请下载并填写 这份表格并发邮件到approved-manufacturers@chemwhat.com |
其他供应商 | |
| Watson International Limited | 访问Watson官网 |
如需其他帮助，请联系我们 | |
| 联系我们获取其它信息或服务 | 点击这里联系凯望 |